A novel tyrosine kinase inhibitor restores chondrocyte differentiation and promotes bone growth in a gain-of-function Fgfr3 mouse model.

Activating germline fibroblast growth factor receptor 3 (FGFR3) mutations cause achondroplasia (ACH), the most common form of human dwarfism and a spectrum of skeletal dysplasias. FGFR3 is a tyrosine kinase receptor and constitutive FGFR3 activation impairs endochondral ossification and triggers severe disorganization of the cartilage with shortening of long bones. To decipher the role of FGFR3 in endochondral ossification, we analyzed the impact of a novel tyrosine kinase inhibitor (TKI), A31, on both human and mouse mutant FGFR3-expressing cells and on the skeleton of Fgfr3(Y367C/+) dwarf mice. We found that A31 inhibited constitutive FGFR3 phosphorylation and restored the size of embryonic dwarf femurs using an ex vivo culture system. The increase in length of the treated mutant femurs was 2.6 times more than for the wild-type. Premature cell cycle exit and defective chondrocyte differentiation were observed in the Fgfr3(Y367C/+) growth plate. A31 restored normal expression of cell cycle regulators (proliferating cell nuclear antigen, KI67, cyclin D1 and p57) and allowed pre-hypertrophic chondrocytes to properly differentiate into hypertrophic chondocytes. Our data reveal a specific role for FGFR3 in the cell cycle and chondrocyte differentiation and support the development of TKIs for the treatment of FGFR3-related chondrodysplasias.

[1]  A. Munnich,et al.  Delayed bone age due to a dual effect of FGFR3 mutation in Achondroplasia. , 2010, Bone.

[2]  M. Laederich,et al.  Achondroplasia: pathogenesis and implications for future treatment , 2010, Current opinion in pediatrics.

[3]  François Radvanyi,et al.  Synthesis and biological evaluation of a triazole-based library of pyrido[2,3-d]pyrimidines as FGFR3 tyrosine kinase inhibitors. , 2010, Organic & biomolecular chemistry.

[4]  S. Anai,et al.  1-tert-Butyl-3-[6-(3,5-dimethoxy-phenyl)-2-(4-diethylamino-butylamino)-pyrido[2,3-d]pyrimidin-7-yl]-urea (PD173074), a Selective Tyrosine Kinase Inhibitor of Fibroblast Growth Factor Receptor-3 (FGFR3), Inhibits Cell Proliferation of Bladder Cancer Carrying the FGFR3 Gene Mutation along with Up-Regu , 2010, Journal of Pharmacology and Experimental Therapeutics.

[5]  William L Jorgensen,et al.  Discovery of novel fibroblast growth factor receptor 1 kinase inhibitors by structure-based virtual screening. , 2010, Journal of medicinal chemistry.

[6]  David D. McErlain,et al.  The role of Akt1 in terminal stages of endochondral bone formation: angiogenesis and ossification. , 2009, Bone.

[7]  A. Munnich,et al.  New Insight on FGFR3-Related Chondrodysplasias Molecular Physiopathology Revealed by Human Chondrocyte Gene Expression Profiling , 2009, PloS one.

[8]  C. Degnin,et al.  FGFs in endochondral skeletal development , 2009, Trends in Endocrinology & Metabolism.

[9]  Ruisheng Zhang,et al.  Receptor- and ligand-based 3D-QSAR study for a series of non-nucleoside HIV-1 reverse transcriptase inhibitors. , 2009, Bioorganic & medicinal chemistry.

[10]  Kozo Nakamura,et al.  C/EBPβ Promotes Transition from Proliferation to Hypertrophic Differentiation of Chondrocytes through Transactivation of p57Kip2 , 2009, PloS one.

[11]  A. Munnich,et al.  Activating Fgfr3 Y367C mutation causes hearing loss and inner ear defect in a mouse model of chondrodysplasia. , 2009, Biochimica et biophysica acta.

[12]  A. Kawanami,et al.  FGFR3 promotes synchondrosis closure and fusion of ossification centers through the MAPK pathway. , 2008, Human molecular genetics.

[13]  N. Gray,et al.  Targeting cancer with small molecule kinase inhibitors , 2009, Nature Reviews Cancer.

[14]  François Maurel,et al.  Cellular interaction through LewisX cluster: theoretical studies , 2008, Journal of molecular modeling.

[15]  L. Thompson,et al.  STAT1 and STAT3 do not participate in FGF-mediated growth arrest in chondrocytes , 2008, Journal of Cell Science.

[16]  T. I. Morales,et al.  Chondrocyte moves: clever strategies? , 2007, Osteoarthritis and cartilage.

[17]  A. Munnich,et al.  Human immortalized chondrocytes carrying heterozygous FGFR3 mutations: An in vitro model to study chondrodysplasias , 2007, FEBS letters.

[18]  R. Baron,et al.  The localization of FGFR3 mutations causing thanatophoric dysplasia type I differentially affects phosphorylation, processing and ubiquitylation of the receptor , 2007, The FEBS journal.

[19]  J. Pouysségur,et al.  The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition , 2007, Oncogene.

[20]  L. Gibbs,et al.  FGFR3 intracellular mutations induce tyrosine phosphorylation in the Golgi and defective glycosylation. , 2007, Biochimica et biophysica acta.

[21]  D. Ornitz,et al.  FGF18 is required for early chondrocyte proliferation, hypertrophy and vascular invasion of the growth plate. , 2007, Developmental biology.

[22]  H. E. Maclean,et al.  The cyclin-dependent kinase inhibitor p57(Kip2) mediates proliferative actions of PTHrP in chondrocytes. , 2004, The Journal of clinical investigation.

[23]  S. Murakami,et al.  Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype. , 2004, Genes & development.

[24]  Tomoko Iwata,et al.  Defective lysosomal targeting of activated fibroblast growth factor receptor 3 in achondroplasia. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[25]  A. Munnich,et al.  Overexpression of FGFR3, Stat1, Stat5 and p21Cip1 correlates with phenotypic severity and defective chondrocyte differentiation in FGFR3-related chondrodysplasias. , 2004, Bone.

[26]  E. Laplantine,et al.  A network of transcriptional and signaling events is activated by FGF to induce chondrocyte growth arrest and differentiation , 2003, The Journal of cell biology.

[27]  R. Adar,et al.  FGF receptors ubiquitylation: dependence on tyrosine kinase activity and role in downregulation , 2002, FEBS letters.

[28]  Andrea Vortkamp,et al.  Interaction of FGF, Ihh/Pthlh, and BMP signaling integrates chondrocyte proliferation and hypertrophic differentiation. , 2002, Developmental cell.

[29]  Christophe G. Lambert,et al.  ESyPred3D: Prediction of proteins 3D structures , 2002, Bioinform..

[30]  O. Rozenblatt-Rosen,et al.  Induction of chondrocyte growth arrest by FGF: transcriptional and cytoskeletal alterations. , 2002, Journal of cell science.

[31]  C. Lambert,et al.  ESyPred 3 D : Prediction of proteins 3 D structures , 2002 .

[32]  C. Albanese,et al.  TGFbeta and PTHrP control chondrocyte proliferation by activating cyclin D1 expression. , 2001, Molecular biology of the cell.

[33]  C. Deng,et al.  A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos. , 2000, Human molecular genetics.

[34]  F. Beier,et al.  Cell cycle control in growth plate chondrocytes. , 2000, Frontiers in bioscience : a journal and virtual library.

[35]  D. Givol,et al.  Restrained chondrocyte proliferation and maturation with abnormal growth plate vascularization and ossification in human FGFR-3(G380R) transgenic mice. , 2000, Human molecular genetics.

[36]  R. Adar,et al.  The Transmembrane Mutation G380R in Fibroblast Growth Factor Receptor 3 Uncouples Ligand-Mediated Receptor Activation from Down-Regulation , 2000, Molecular and Cellular Biology.

[37]  S. Pol,et al.  Delayed Union of Fractures, with Cases and Illustrations; the Successful Employment of Malgaigne’s Spike in Connection with Drilling, in a Case Which Had Previously Resisted Drilling Employed by Itself , 1863, Chicago medical examiner.

[38]  C. Deng,et al.  A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors. , 1999, Human molecular genetics.

[39]  D. Ornitz,et al.  Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3. , 1998, Development.

[40]  A. Munnich,et al.  Fibroblast Growth Factor Receptor 3 Mutations Promote Apoptosis but Do Not Alter Chondrocyte Proliferation in Thanatophoric Dysplasia* , 1998, The Journal of Biological Chemistry.

[41]  David S. Goodsell,et al.  Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function , 1998, J. Comput. Chem..

[42]  A. Munnich,et al.  Abnormal FGFR 3 expression in cartilage of thanatophoric dysplasia fetuses. , 1997, Human molecular genetics.

[43]  S. Elledge,et al.  Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith–Wiedemann syndrome , 1997, Nature.

[44]  M. Barbacid,et al.  Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. , 1997, Genes & development.

[45]  Xin-Yuan Fu,et al.  Activation of Statl by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism , 1997, Nature.

[46]  John Kuriyan,et al.  Structure of the C-Terminal Region of p21WAF1/CIP1 Complexed with Human PCNA , 1996, Cell.

[47]  J. Weissenbach,et al.  Clinical and genetic heterogeneity of hypochondroplasia. , 1996, Journal of medical genetics.

[48]  Gary W. Harding,et al.  Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3 , 1996, Nature Genetics.

[49]  A. Munnich,et al.  Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1). , 1996, Human molecular genetics.

[50]  P. Leder,et al.  Fibroblast Growth Factor Receptor 3 Is a Negative Regulator of Bone Growth , 1996, Cell.

[51]  I. Kaitila,et al.  A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia , 1995, Nature Genetics.

[52]  A. Munnich,et al.  Stop codon FGFR3 mutations in thanatophoric dwarfism type 1 , 1995, Nature Genetics.

[53]  D. Rimoin,et al.  Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3 , 1995, Nature Genetics.

[54]  T. Blankenship,et al.  Developmental expression of Ki‐67 antigen and proliferating cell nuclear antigen in macaque placentas , 1994, Developmental dynamics : an official publication of the American Association of Anatomists.

[55]  Arnold Munnich,et al.  Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia , 1994, Nature.

[56]  D. Church,et al.  Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia , 1994, Cell.

[57]  Hui Zhang,et al.  D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA , 1992, Cell.